HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use CORLOPAM® safely and effectively. See full prescribing information for CORLOPAM®.
CORLOPAM® (fenoldopam mesylate) injection, for intravenous use
Initial U.S. Approval: 1997
INDICATIONS AND USAGE
Fenoldopam injection is a dopaminergic agonist indicated:
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
WARNINGS AND PRECAUTIONS
Beta-blockers: Avoid concomitant use (7.1).
See 17 for PATIENT COUNSELING INFORMATION.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.